318 related articles for article (PubMed ID: 22550965)
1. Role of interleukin-1 inhibitors in osteoarthritis: an evidence-based review.
Jotanovic Z; Mihelic R; Sestan B; Dembic Z
Drugs Aging; 2012 May; 29(5):343-58. PubMed ID: 22550965
[TBL] [Abstract][Full Text] [Related]
2. Anticytokine therapy for osteoarthritis: evidence to date.
Malemud CJ
Drugs Aging; 2010 Feb; 27(2):95-115. PubMed ID: 20104937
[TBL] [Abstract][Full Text] [Related]
3. The role of cytokines in osteoarthritis pathophysiology.
Fernandes JC; Martel-Pelletier J; Pelletier JP
Biorheology; 2002; 39(1-2):237-46. PubMed ID: 12082286
[TBL] [Abstract][Full Text] [Related]
4. IL-1β receptor antagonist (IL-1Ra) combined with autophagy inducer (TAT-Beclin1) is an effective alternative for attenuating extracellular matrix degradation in rat and human osteoarthritis chondrocytes.
Wang F; Liu J; Chen X; Zheng X; Qu N; Zhang B; Xia C
Arthritis Res Ther; 2019 Jul; 21(1):171. PubMed ID: 31291980
[TBL] [Abstract][Full Text] [Related]
5. The association of peripheral monocyte derived interleukin 1beta (IL-1beta), IL-1 receptor antagonist, and tumor necrosis factor-alpha with osteoarthritis in the elderly.
Fraenkel L; Roubenoff R; LaValley M; McAlindon T; Chaisson C; Evans S; Harris T; Dinarello CA; Felson DT
J Rheumatol; 1998 Sep; 25(9):1820-6. PubMed ID: 9733466
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-1beta induced activation of nuclear factor-kappab can be inhibited by novel pharmacological agents in osteoarthritis.
Lauder SN; Carty SM; Carpenter CE; Hill RJ; Talamas F; Bondeson J; Brennan P; Williams AS
Rheumatology (Oxford); 2007 May; 46(5):752-8. PubMed ID: 17218328
[TBL] [Abstract][Full Text] [Related]
7. Anticytokine therapy for osteoarthritis.
Goldring MB
Expert Opin Biol Ther; 2001 Sep; 1(5):817-29. PubMed ID: 11728217
[TBL] [Abstract][Full Text] [Related]
8. [Targeted anti-cytokine therapies for osteoarthritis].
Chevalier X; Mugnier B; Bouvenot G
Bull Acad Natl Med; 2006 Oct; 190(7):1411-20; discussion 1420, 1475-7. PubMed ID: 17450677
[TBL] [Abstract][Full Text] [Related]
9. Emerging pathways and promising agents with possible disease modifying effect in osteoarthritis treatment.
Jotanovic Z; Mihelic R; Sestan B; Dembic Z
Curr Drug Targets; 2014 Jun; 15(6):635-61. PubMed ID: 24597569
[TBL] [Abstract][Full Text] [Related]
10. Reversal of autocrine and paracrine effects of interleukin 1 (IL-1) in human arthritis by type II IL-1 decoy receptor. Potential for pharmacological intervention.
Attur MG; Dave M; Cipolletta C; Kang P; Goldring MB; Patel IR; Abramson SB; Amin AR
J Biol Chem; 2000 Dec; 275(51):40307-15. PubMed ID: 11007768
[TBL] [Abstract][Full Text] [Related]
11. Osteoarthritis: can anti-cytokine therapy play a role in treatment?
Calich AL; Domiciano DS; Fuller R
Clin Rheumatol; 2010 May; 29(5):451-5. PubMed ID: 20108016
[TBL] [Abstract][Full Text] [Related]
12. Niacinamide therapy for osteoarthritis--does it inhibit nitric oxide synthase induction by interleukin 1 in chondrocytes?
McCarty MF; Russell AL
Med Hypotheses; 1999 Oct; 53(4):350-60. PubMed ID: 10608273
[TBL] [Abstract][Full Text] [Related]
13. Osteoarthritis gene therapy.
Evans CH; Gouze JN; Gouze E; Robbins PD; Ghivizzani SC
Gene Ther; 2004 Feb; 11(4):379-89. PubMed ID: 14724685
[TBL] [Abstract][Full Text] [Related]
14. [Importance of interleukin-I receptors in osteoarthritis].
Martel-Pelletier J; Pelletier JP
Rev Rhum Ed Fr; 1994 Nov; 61(9 Pt 2):109S-113S. PubMed ID: 7858606
[TBL] [Abstract][Full Text] [Related]
15. Inducible nitric oxide synthase as a target for osteoarthritis treatment.
Leonidou A; Lepetsos P; Mintzas M; Kenanidis E; Macheras G; Tzetis M; Potoupnis M; Tsiridis E
Expert Opin Ther Targets; 2018 Apr; 22(4):299-318. PubMed ID: 29504411
[TBL] [Abstract][Full Text] [Related]
16. The role of cytokines as inflammatory mediators in osteoarthritis: lessons from animal models.
Goldring MB
Connect Tissue Res; 1999; 40(1):1-11. PubMed ID: 10770646
[TBL] [Abstract][Full Text] [Related]
17. Rationale for the use of structure-modifying drugs and agents in the treatment of osteoarthritis.
Pelletier JP
Osteoarthritis Cartilage; 2004; 12 Suppl A():S63-8. PubMed ID: 14698646
[TBL] [Abstract][Full Text] [Related]
18. Cryptotanshinone protects against IL-1β-induced inflammation in human osteoarthritis chondrocytes and ameliorates the progression of osteoarthritis in mice.
Feng Z; Zheng W; Li X; Lin J; Xie C; Li H; Cheng L; Wu A; Ni W
Int Immunopharmacol; 2017 Sep; 50():161-167. PubMed ID: 28666239
[TBL] [Abstract][Full Text] [Related]
19. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis.
Kapoor M; Martel-Pelletier J; Lajeunesse D; Pelletier JP; Fahmi H
Nat Rev Rheumatol; 2011 Jan; 7(1):33-42. PubMed ID: 21119608
[TBL] [Abstract][Full Text] [Related]
20. Wogonin, a plant derived small molecule, exerts potent anti-inflammatory and chondroprotective effects through the activation of ROS/ERK/Nrf2 signaling pathways in human Osteoarthritis chondrocytes.
Khan NM; Haseeb A; Ansari MY; Devarapalli P; Haynie S; Haqqi TM
Free Radic Biol Med; 2017 May; 106():288-301. PubMed ID: 28237856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
